cannabinol has been researched along with Disease Models, Animal in 5 studies
Cannabinol: A physiologically inactive constituent of Cannabis sativa L.
Disease Models, Animal: Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Glaucoma is characterized by progressive damage of the retinal ganglion cells (RGCs), resulting in irreversible vision loss." | 5.72 | Cannabinol modulates neuroprotection and intraocular pressure: A potential multi-target therapeutic intervention for glaucoma. ( Hsu, E; Kadhim, S; Kumar, U; Padania, S; Somvanshi, RK; Zou, S, 2022) |
| "Glaucoma is characterized by progressive damage of the retinal ganglion cells (RGCs), resulting in irreversible vision loss." | 1.72 | Cannabinol modulates neuroprotection and intraocular pressure: A potential multi-target therapeutic intervention for glaucoma. ( Hsu, E; Kadhim, S; Kumar, U; Padania, S; Somvanshi, RK; Zou, S, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Somvanshi, RK | 1 |
| Zou, S | 1 |
| Kadhim, S | 1 |
| Padania, S | 1 |
| Hsu, E | 1 |
| Kumar, U | 1 |
| Wong, H | 1 |
| Cairns, BE | 1 |
| Gratzke, C | 1 |
| Streng, T | 1 |
| Stief, CG | 1 |
| Alroy, I | 1 |
| Limberg, BJ | 1 |
| Downs, TR | 1 |
| Rosenbaum, JS | 1 |
| Hedlund, P | 1 |
| Andersson, KE | 1 |
| Jan, TR | 1 |
| Farraj, AK | 1 |
| Harkema, JR | 1 |
| Kaminski, NE | 1 |
| Izzo, AA | 1 |
| Fezza, F | 1 |
| Capasso, R | 1 |
| Bisogno, T | 1 |
| Pinto, L | 1 |
| Iuvone, T | 1 |
| Esposito, G | 1 |
| Mascolo, N | 1 |
| Di Marzo, V | 1 |
| Capasso, F | 1 |
5 other studies available for cannabinol and Disease Models, Animal
| Article | Year |
|---|---|
Cannabinol modulates neuroprotection and intraocular pressure: A potential multi-target therapeutic intervention for glaucoma.
Topics: Animals; Cannabinol; Disease Models, Animal; Glaucoma; Intraocular Pressure; Male; Mice; Neuroprotec | 2022 |
Cannabidiol, cannabinol and their combinations act as peripheral analgesics in a rat model of myofascial pain.
Topics: Analgesics; Animals; Cannabidiol; Cannabinol; Disease Models, Animal; Female; Myofascial Pain Syndro | 2019 |
Cannabinor, a selective cannabinoid-2 receptor agonist, improves bladder emptying in rats with partial urethral obstruction.
Topics: Animals; Cannabinol; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration S | 2011 |
Attenuation of the ovalbumin-induced allergic airway response by cannabinoid treatment in A/J mice.
Topics: Adjuvants, Immunologic; Animals; Bronchoalveolar Lavage Fluid; Cannabinoids; Cannabinol; Cytokines; | 2003 |
Cannabinoid CB1-receptor mediated regulation of gastrointestinal motility in mice in a model of intestinal inflammation.
Topics: Analgesics; Animals; Cannabinoid Receptor Modulators; Cannabinoids; Cannabinol; Croton Oil; Cyclohex | 2001 |